Second-line treatment for chronic tuberculosis
Lancet
.
2002 Nov 2;360(9343):1430.
doi: 10.1016/S0140-6736(02)11388-2.
Authors
Prasanta R Mohapatra
,
Ashok K Janmeja
,
Varinder Saini
,
Suman K Das
,
Anirban Deb
PMID:
12424025
DOI:
10.1016/S0140-6736(02)11388-2
No abstract available
Publication types
Comment
Letter
MeSH terms
Antitubercular Agents / therapeutic use*
Humans
Treatment Outcome
Tuberculosis, Multidrug-Resistant / drug therapy*
Substances
Antitubercular Agents